Detalhe da pesquisa
1.
Disruption of CerS6-mediated sphingolipid metabolism by FTO deficiency aggravates ulcerative colitis.
Gut
; 73(2): 268-281, 2024 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37734910
2.
Gut microbiome for predicting immune checkpoint blockade-associated adverse events.
Genome Med
; 16(1): 16, 2024 Jan 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38243343
3.
A specific enterotype derived from gut microbiome of older individuals enables favorable responses to immune checkpoint blockade therapy.
Cell Host Microbe
; 32(4): 489-505.e5, 2024 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38513657
4.
Multi-center evaluation of machine learning-based radiomic model in predicting disease free survival and adjuvant chemotherapy benefit in stage II colorectal cancer patients.
Cancer Imaging
; 23(1): 74, 2023 Aug 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37537659
5.
Commensal bacteria promote azathioprine therapy failure in inflammatory bowel disease via decreasing 6-mercaptopurine bioavailability.
Cell Rep Med
; 4(8): 101153, 2023 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37586320
6.
Microbiome and metabolome features in inflammatory bowel disease via multi-omics integration analyses across cohorts.
Nat Commun
; 14(1): 7135, 2023 11 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37932270
7.
Multi-kingdom gut microbiota analyses define bacterial-fungal interplay and microbial markers of pan-cancer immunotherapy across cohorts.
Cell Host Microbe
; 31(11): 1930-1943.e4, 2023 11 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37944495
8.
Overview on new progress of hereditary diffuse gastric cancer with CDH1 variants.
Tumori
; 106(5): 346-355, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32811340
9.
Synchronous multiple primary gastrointestinal cancers with CDH1 mutations: A case report.
World J Clin Cases
; 7(13): 1703-1710, 2019 Jul 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31367630